EE656 A Cost-Utility Analysis of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, a Rare Disease, in Spain
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.895
https://www.valueinhealthjournal.com/article/S1098-3015(22)03099-6/fulltext
Title :
EE656 A Cost-Utility Analysis of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, a Rare Disease, in Spain
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03099-6&doi=10.1016/j.jval.2022.09.895
First page :
Section Title :
Open access? :
No
Section Order :
10440